GSI (Complera emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg)
Generic Name: emtricitabine/rilpivirine/tenofovir
Pill with imprint GSI is Pink, Capsule-shape and has been identified as Complera emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg. It is supplied by Gilead Sciences, Inc.
Complera is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Complera emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GSI

Complera
- Generic Name
- emtricitabine/rilpivirine/tenofovir
- Imprint
- GSI
- Strength
- emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg
- Color
- Pink
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- National Drug Code (NDC)
- 61958-1101
- Inactive Ingredients
-
microcrystalline cellulose,
lactose monohydrate,
polysorbate 20,
croscarmellose sodium,
magnesium stearate,
corn starch,
FD&C Blue No. 2,
aluminum oxide,
ferric oxide red,
FD&C Yellow No. 6,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
Related images for "GSI"
More about Complera (emtricitabine / rilpivirine / tenofovir)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (58)
- Drug images
- Pricing & coupons
- En español
- Drug class: antiviral combinations
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.